Protocols
1 protocol(s) meet the specified criteria
Drug: PEG-Interferon Alfa-2a
Protocol No.TitleStatus
GO29322A Phase Ib Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered with Ipilimumab, Interferon-Alpha, or Other Immune-Modulating Therapies in Patients with Locally Advanced or Metastatic Solid TumorsOpen